Publicacións nas que colabora con LUIS FONTANA GALLEGO (21)

2023

  1. Editorial: Interplay between gut microbiota and the immune system in liver surgery and liver diseases

    Frontiers in Cellular and Infection Microbiology

2022

  1. Bifidobacterium longum subsp. infantis CECT 7210 Reduces Inflammatory Cytokine Secretion in Caco-2 Cells Cultured in the Presence of Escherichia coli CECT 515

    International journal of molecular sciences, Vol. 23, Núm. 18

2021

  1. Bifidobacterium breve CNCM i-4035, lactobacillus paracasei cncm i-4034 and lactobacillus rhamnosus cncm i-4036 modulate macrophage gene expression and ameliorate damage markers in the liver of zucker-leprfa/fa rats

    Nutrients, Vol. 13, Núm. 1, pp. 1-14

  2. Differential inflammatory response of men and women subjected to an acute resistance exercise

    Biomedical Journal, Vol. 44, Núm. 3, pp. 338-345

  3. NAIP expression increases in a rat model of liver mass restoration

    Journal of Molecular Histology, Vol. 52, Núm. 1, pp. 113-123

2020

  1. Differential IL 10 serum production between an arm-based and a leg-based maximal resistance test

    Cytokine, Vol. 126

2019

  1. Association of breast and gut microbiota dysbiosis and the risk of breast cancer: A case-control clinical study

    BMC Cancer, Vol. 19, Núm. 1

  2. Lactobacillus reuteri v3401 reduces inflammatory biomarkers and modifies the gastrointestinal microbiome in adults with metabolic syndrome: The PROSIR study

    Nutrients, Vol. 11, Núm. 8

  3. Microbial population changes and their relationship with human health and disease

    Microorganisms, Vol. 7, Núm. 3

2018

  1. A novel electromyographic approach to estimate fatigue threshold in maximum incremental strength tests

    Motor Control, Vol. 22, Núm. 2, pp. 170-182

  2. Breast cancer and its relationship with the microbiota

    International Journal of Environmental Research and Public Health, Vol. 15, Núm. 8

  3. Evaluation of the effect of Lactobacillus reuteri V3401 on biomarkers of inflammation, cardiovascular risk and liver steatosis in obese adults with metabolic syndrome: A randomized clinical trial (PROSIR)

    BMC Complementary and Alternative Medicine, Vol. 18, Núm. 1

  4. Human milk oligosaccharides and immune system development

    Nutrients, Vol. 10, Núm. 8

2017

  1. Adamdec1, Ednrb and Ptgs1/Cox1, inflammation genes upregulated in the intestinal mucosa of obese rats, are downregulated by three probiotic strains

    Scientific Reports, Vol. 7, Núm. 1

  2. Gene expression profiling in the intestinal mucosa of obese rats administered probiotic bacteria

    Scientific Data, Vol. 4

2015

  1. Pyrosequencing analysis reveals changes in intestinal microbiota of healthy adults who received a daily dose of immunomodulatory probiotic strains

    Nutrients, Vol. 7, Núm. 6, pp. 3999-4015

2014

  1. Effects of Lactobacillus paracasei CNCM I-4034, Bifidobacterium breve CNCM I-4035 and Lactobacillus rhamnosus CNCM I-4036 on hepatic steatosis in Zucker rats

    PLoS ONE, Vol. 9, Núm. 5

  2. Modulation of immunity and inflammatory gene expression in the gut, in inflammatory diseases of the gut and in the liver by probiotics

    World Journal of Gastroenterology, Vol. 20, Núm. 42, pp. 15632-15649

2013

  1. In vitro cell and tissue models for studying host-microbe interactions: A review

    British Journal of Nutrition, Vol. 109, Núm. SUPPL. 2

  2. Safety and Immunomodulatory Effects of Three Probiotic Strains Isolated from the Feces of Breast-Fed Infants in Healthy Adults: SETOPROB Study

    PLoS ONE, Vol. 8, Núm. 10